Skip to main content
Top
Published in: BMC Health Services Research 1/2024

Open Access 01-12-2024 | Cervical Cancer | Research

Early age at menarche and history of sexually transmitted infections significantly predict cervical cancer screening uptake among women aged 25–49 years: evidence from the 2021 Côte d’Ivoire demographic and health survey

Authors: Joshua Okyere, Castro Ayebeng, Kwamena Sekyi Dickson

Published in: BMC Health Services Research | Issue 1/2024

Login to get access

Abstract

Introduction

Cervical cancer is the second dominant type of cancer among Ivorian women with an estimated age-standardised incidence and mortality rate of 31.2 cases and 22.8 deaths per 100,000 women in 2020, respectively. The Ivorian government through its Ministry of Health implemented the National Cancer Control Programme (NCCP) in 2003 with the aim of improving the prevention, early detection and treatment of cancers in Côte d’Ivoire. Yet, there is a low uptake of CCS (1.2%). Thus, making CCS uptake an important public health concern in the country. Understanding of the extent to which reproductive factors predict CCS uptake is limited in literature. This study aimed to investigate reproductive factors as a predictor of women’s uptake of CCS in Côte d’Ivoire.

Methods

Data from the 2021 Côte d’Ivoire Demographic and Health Survey. A sample of 9,078 women aged 25–49 years were analyzed. The outcome variable was CCS uptake while other variables considered included age at menarche, history of STI, sexual debut, parity, age, educational level, wealth index, health insurance, place of residence, and media exposure. A multivariable logistic regression model was fitted to examine the association between the outcome of interest and predictors at 95% confidence interval.

Results

Approximately, 7.52% of women aged 25–49 years had ever undergone testing for cervical cancer by a healthcare provider. Early menarche was associated with lower odds of CCS uptake [AOR = 0.78; CI = 0.65–0.95]. Compared to those who had no STI, women with a history of STI were more likely to screen for cervical cancer [AOR = 2.63; CI = 2.02–3.42]. Increasing age, higher educational attainment, having health insurance, and being exposed to media were significantly associated with CCS uptake.

Conclusion

In Cote d’Ivoire, age at menarche and STI history constitute reproductive factors that were significantly associated with women’s uptake of CCS. It is imperative for public policy to focus on increasing CCS in these higher-risk women (i.e., women who experienced early menarche, women with early sexual debut and higher parity) through increased sensitization on cervical cancer risk factors.
Appendix
Available only for authorised users
Literature
1.
go back to reference Brisson M, Drolet M. Global elimination of cervical cancer as a public health problem. Lancet Oncol. 2019;20(3):319–21.CrossRefPubMed Brisson M, Drolet M. Global elimination of cervical cancer as a public health problem. Lancet Oncol. 2019;20(3):319–21.CrossRefPubMed
3.
go back to reference Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209–49.CrossRef Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209–49.CrossRef
4.
go back to reference Bruni L, Albero G, Serrano B, Mena M, Collado JJ, Gómez D. Human papillomavirus and related diseases in the world. ICO/IARC information centre on HPV and cancer (HPV information centre), 2019. Acceso. 2021;10(06). Bruni L, Albero G, Serrano B, Mena M, Collado JJ, Gómez D. Human papillomavirus and related diseases in the world. ICO/IARC information centre on HPV and cancer (HPV information centre), 2019. Acceso. 2021;10(06).
6.
go back to reference Plaisy MK, Boni SP, Coffie PA, Tanon A, Innocent A, Horo A, Dabis F, Bekelynck A, Jaquet A. IeDEA West Africa collaboration. Barriers to early diagnosis of cervical cancer: a mixed-method study in Côte d’Ivoire, West Africa. BMC Womens Health. 2023;23(1):135.CrossRefPubMedPubMedCentral Plaisy MK, Boni SP, Coffie PA, Tanon A, Innocent A, Horo A, Dabis F, Bekelynck A, Jaquet A. IeDEA West Africa collaboration. Barriers to early diagnosis of cervical cancer: a mixed-method study in Côte d’Ivoire, West Africa. BMC Womens Health. 2023;23(1):135.CrossRefPubMedPubMedCentral
7.
go back to reference Boni SP, Gnahatin F, Comoé JC, Tchounga B, Ekouevi D, Horo A, Adoubi I, Jaquet A. Barriers and facilitators in cervical cancer screening uptake in Abidjan, Côte d’Ivoire in 2018: a cross-sectional study. BMC Cancer. 2021;21(1):1–8.CrossRef Boni SP, Gnahatin F, Comoé JC, Tchounga B, Ekouevi D, Horo A, Adoubi I, Jaquet A. Barriers and facilitators in cervical cancer screening uptake in Abidjan, Côte d’Ivoire in 2018: a cross-sectional study. BMC Cancer. 2021;21(1):1–8.CrossRef
8.
go back to reference Fontham ET, Wolf AM, Church TR, Etzioni R, Flowers CR, Herzig A, Guerra CE, Oeffinger KC, Shih YC, Walter LC, Kim JJ. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA: a cancer journal for clinicians. 2020;70(5):321–46. Fontham ET, Wolf AM, Church TR, Etzioni R, Flowers CR, Herzig A, Guerra CE, Oeffinger KC, Shih YC, Walter LC, Kim JJ. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA: a cancer journal for clinicians. 2020;70(5):321–46.
9.
go back to reference Boni S, Tchounga B, Comoe K, Guie P, Adié M, Horo A, Messou E, Ekouévi DK, Dabis F, Adoubi I, Jaquet A. Assessment of the scale-up of cervical cancer screening in Abidjan stratified by HIV status. Int J Gynecol Obstet. 2019;147(2):246–51.CrossRef Boni S, Tchounga B, Comoe K, Guie P, Adié M, Horo A, Messou E, Ekouévi DK, Dabis F, Adoubi I, Jaquet A. Assessment of the scale-up of cervical cancer screening in Abidjan stratified by HIV status. Int J Gynecol Obstet. 2019;147(2):246–51.CrossRef
10.
go back to reference Okyere J, Duodu PA, Aduse-Poku L, Agbadi P, Nutor JJ. Cervical cancer screening prevalence and its correlates in Cameroon: secondary data analysis of the 2018 demographic and health surveys. BMC Public Health. 2021;21(1):1–8.CrossRef Okyere J, Duodu PA, Aduse-Poku L, Agbadi P, Nutor JJ. Cervical cancer screening prevalence and its correlates in Cameroon: secondary data analysis of the 2018 demographic and health surveys. BMC Public Health. 2021;21(1):1–8.CrossRef
11.
go back to reference Pillai AB, Wong CM, Abidin ND, Nor SF, Hanan MF, Abd Ghani SR, Aminuddin NA, Safian N. Chlamydia infection as a risk factor for cervical cancer: a systematic review and meta-analysis. Iran J Public Health. 2022;51(3):508. Pillai AB, Wong CM, Abidin ND, Nor SF, Hanan MF, Abd Ghani SR, Aminuddin NA, Safian N. Chlamydia infection as a risk factor for cervical cancer: a systematic review and meta-analysis. Iran J Public Health. 2022;51(3):508.
12.
go back to reference Zhao M, Gu RY, Ding SR, Luo L, Jia Y, Gao CX, Chen B, Xu XB, Chen HF. Risk factors of cervical cancer among ethnic minorities in Yunnan Province, China: a case–control study. Eur J Cancer Prev. 2022;31(3):287.CrossRefPubMed Zhao M, Gu RY, Ding SR, Luo L, Jia Y, Gao CX, Chen B, Xu XB, Chen HF. Risk factors of cervical cancer among ethnic minorities in Yunnan Province, China: a case–control study. Eur J Cancer Prev. 2022;31(3):287.CrossRefPubMed
13.
go back to reference Sharma P, Pattanshetty SM. A study on risk factors of cervical cancer among patients attending a tertiary care hospital: a case-control study. Clin Epidemiol Global Health. 2018;6(2):83–7.CrossRef Sharma P, Pattanshetty SM. A study on risk factors of cervical cancer among patients attending a tertiary care hospital: a case-control study. Clin Epidemiol Global Health. 2018;6(2):83–7.CrossRef
14.
go back to reference Corsi DJ, Neuman M, Finlay JE, Subramanian SV. Demographic and health surveys: a profile. Int J Epidemiol. 2012;41(6):1602–13.CrossRefPubMed Corsi DJ, Neuman M, Finlay JE, Subramanian SV. Demographic and health surveys: a profile. Int J Epidemiol. 2012;41(6):1602–13.CrossRefPubMed
15.
go back to reference Institut National de la Statistique-INS et ICF. Enquête Démographique et de Santé de Côte d’Ivoire, 2021. Maryland, USA: INS/Côte d’Ivoire et ICF: Rockville; 2023. Institut National de la Statistique-INS et ICF. Enquête Démographique et de Santé de Côte d’Ivoire, 2021. Maryland, USA: INS/Côte d’Ivoire et ICF: Rockville; 2023.
16.
go back to reference Cunningham MS, Skrastins E, Fitzpatrick R, Jindal P, Oneko O, Yeates K, Booth CM, Carpenter J, Aronson KJ. Cervical cancer screening and HPV vaccine acceptability among rural and urban women in Kilimanjaro Region, Tanzania. BMJ open. 2015;5(3). Cunningham MS, Skrastins E, Fitzpatrick R, Jindal P, Oneko O, Yeates K, Booth CM, Carpenter J, Aronson KJ. Cervical cancer screening and HPV vaccine acceptability among rural and urban women in Kilimanjaro Region, Tanzania. BMJ open. 2015;5(3).
17.
go back to reference Ndejjo R, Mukama T, Musabyimana A, Musoke D. Uptake of cervical cancer screening and associated factors among women in rural Uganda: a cross sectional study. PLoS ONE. 2016;11(2):e0149696.CrossRefPubMedPubMedCentral Ndejjo R, Mukama T, Musabyimana A, Musoke D. Uptake of cervical cancer screening and associated factors among women in rural Uganda: a cross sectional study. PLoS ONE. 2016;11(2):e0149696.CrossRefPubMedPubMedCentral
18.
go back to reference Kilic C. Association of Human Papillomavirus and Chlamydia trachomatis Coinfection with Cervical Intraepithelial lesions and Cervical Cancer. Curr Obstet Gynecol Rep. 2022 Mar:1–4. Kilic C. Association of Human Papillomavirus and Chlamydia trachomatis Coinfection with Cervical Intraepithelial lesions and Cervical Cancer. Curr Obstet Gynecol Rep. 2022 Mar:1–4.
19.
go back to reference Khan AA, Abuderman A, Ashraf A, Khan MT. Protein–protein interactions of HPV–Chlamydia trachomatis–human and their potential in cervical cancer. Future Microbiol. 2020;15(7):509–20.CrossRefPubMed Khan AA, Abuderman A, Ashraf A, Khan MT. Protein–protein interactions of HPV–Chlamydia trachomatis–human and their potential in cervical cancer. Future Microbiol. 2020;15(7):509–20.CrossRefPubMed
20.
go back to reference Kashyap N, Krishnan N, Kaur S, Ghai S. Risk factors of cervical cancer: a case-control study. Asia-Pacific J Oncol Nurs. 2019;6(3):308–14.CrossRef Kashyap N, Krishnan N, Kaur S, Ghai S. Risk factors of cervical cancer: a case-control study. Asia-Pacific J Oncol Nurs. 2019;6(3):308–14.CrossRef
21.
go back to reference Musa J, Achenbach CJ, Evans CT, Jordan N, Daru PH, Hou L, Murphy RL, Adewole IF, Simon MA. Association between patient-reported HIV status and provider recommendation for screening in an opportunistic cervical Cancer screening setting in Jos, Nigeria. BMC Health Serv Res. 2018;18:1–0.CrossRef Musa J, Achenbach CJ, Evans CT, Jordan N, Daru PH, Hou L, Murphy RL, Adewole IF, Simon MA. Association between patient-reported HIV status and provider recommendation for screening in an opportunistic cervical Cancer screening setting in Jos, Nigeria. BMC Health Serv Res. 2018;18:1–0.CrossRef
23.
go back to reference Phaswana-Mafuya N, Peltzer K. Breast and cervical cancer screening prevalence and associated factors among women in the South African general population. Asian Pac J cancer Prevention: APJCP. 2018;19(6):1465. Phaswana-Mafuya N, Peltzer K. Breast and cervical cancer screening prevalence and associated factors among women in the South African general population. Asian Pac J cancer Prevention: APJCP. 2018;19(6):1465.
24.
go back to reference Compaore S, Ouedraogo CM, Koanda S, Haynatzki G, Chamberlain RM, Soliman AS. Barriers to cervical cancer screening in Burkina Faso: needs for patient and professional education. J Cancer Educ. 2016;31:760–6.CrossRefPubMedPubMedCentral Compaore S, Ouedraogo CM, Koanda S, Haynatzki G, Chamberlain RM, Soliman AS. Barriers to cervical cancer screening in Burkina Faso: needs for patient and professional education. J Cancer Educ. 2016;31:760–6.CrossRefPubMedPubMedCentral
25.
26.
go back to reference Sreedevi A, Javed R, Dinesh A. Epidemiology of cervical cancer with special focus on India. Int J women’s health 2015 Apr 16:405–14. Sreedevi A, Javed R, Dinesh A. Epidemiology of cervical cancer with special focus on India. Int J women’s health 2015 Apr 16:405–14.
27.
go back to reference Dickson KS, Boateng EN, Acquah E, Ayebeng C, Addo IY. Screening for cervical cancer among women in five countries in sub-saharan Africa: analysis of the role played by distance to health facility and socio-demographic factors. BMC Health Serv Res. 2023;23(1):1–0.CrossRef Dickson KS, Boateng EN, Acquah E, Ayebeng C, Addo IY. Screening for cervical cancer among women in five countries in sub-saharan Africa: analysis of the role played by distance to health facility and socio-demographic factors. BMC Health Serv Res. 2023;23(1):1–0.CrossRef
28.
go back to reference Plackett R, Kaushal A, Kassianos AP, Cross A, Lewins D, Sheringham J, Waller J, von Wagner C. Use of social media to promote cancer screening and early diagnosis: scoping review. J Med Internet Res. 2020;22(11):e21582.CrossRefPubMedPubMedCentral Plackett R, Kaushal A, Kassianos AP, Cross A, Lewins D, Sheringham J, Waller J, von Wagner C. Use of social media to promote cancer screening and early diagnosis: scoping review. J Med Internet Res. 2020;22(11):e21582.CrossRefPubMedPubMedCentral
29.
go back to reference Tiruneh FN, Chuang KY, Ntenda PA, Chuang YC. Individual-level and community-level determinants of cervical cancer screening among Kenyan women: a multilevel analysis of a Nationwide survey. BMC Womens Health. 2017;17:1–4.CrossRef Tiruneh FN, Chuang KY, Ntenda PA, Chuang YC. Individual-level and community-level determinants of cervical cancer screening among Kenyan women: a multilevel analysis of a Nationwide survey. BMC Womens Health. 2017;17:1–4.CrossRef
30.
go back to reference Akokuwebe ME, Idemudia ES, Lekulo AM, Motlogeloa OW. Determinants and levels of cervical Cancer screening uptake among women of reproductive age in South Africa: evidence from South Africa demographic and health survey data, 2016. BMC Public Health. 2021;21(1):2013.CrossRefPubMedPubMedCentral Akokuwebe ME, Idemudia ES, Lekulo AM, Motlogeloa OW. Determinants and levels of cervical Cancer screening uptake among women of reproductive age in South Africa: evidence from South Africa demographic and health survey data, 2016. BMC Public Health. 2021;21(1):2013.CrossRefPubMedPubMedCentral
32.
go back to reference Weobong B, Glozah FN, Abdulai HB, Koka E, Addae N, Alor S, Kohl K, Banati P, Adongo PB, Ross DA. Reaching adolescents with health services: systematic development of an adolescent health check-ups programme in Ghana (Y-Check, Ghana). Weobong B, Glozah FN, Abdulai HB, Koka E, Addae N, Alor S, Kohl K, Banati P, Adongo PB, Ross DA. Reaching adolescents with health services: systematic development of an adolescent health check-ups programme in Ghana (Y-Check, Ghana).
Metadata
Title
Early age at menarche and history of sexually transmitted infections significantly predict cervical cancer screening uptake among women aged 25–49 years: evidence from the 2021 Côte d’Ivoire demographic and health survey
Authors
Joshua Okyere
Castro Ayebeng
Kwamena Sekyi Dickson
Publication date
01-12-2024

Other articles of this Issue 1/2024

BMC Health Services Research 1/2024 Go to the issue